Literature DB >> 29115018

Relationship between exercise capacity and glucose tolerance in cystic fibrosis.

Karla Foster1, Guixia Huang2, Nanhua Zhang2, Joseph Crisalli1, Barbara Chini1, Raouf Amin1, Deborah Elder3.   

Abstract

BACKGROUND: Improved exercise capacity (EC) and normal glucose tolerance (NGT) are independently associated with favorable outcomes in CF, however, little information on this relationship exists in patients with CF.
METHODS: Cardiopulmonary exercise tests, oral glucose tolerance tests (OGTT), and HbA1c values measured within a 12-month period were evaluated on 83 pediatric patients diagnosed with CF. Patients were categorized as having NGT, abnormal glucose tolerance (AGT), or CF-related diabetes (CFRD).
RESULTS: EC decreased as severity of glucose intolerance increased across NGT, AGT, and CFRD groups (P = 0.02). Compared to patients with NGT, patients with CFRD had lower peak VO2  mL/kg/min (33.0 ± 7.3 vs 41.3 ± 9.4, P = 0.01), lower VO2 % (81 ± 20 vs 93 ± 17, P = 0.03), and higher HbA1c (6.9 ± 1.7 vs 5.4 ± 0.4, P < 0.01). There was a positive association with age and FEV1 % with EC in the 17 patients with CFRD. In the 66 patients without diabetes, peak EC was positively associated with FEV1 % and negatively associated with age, fasting insulin, and insulin 120 min. After accounting for age and FEV1 %, multivariate analyses indicated that insulin and glucose values at 120 min predicted EC.
CONCLUSIONS: These data provide evidence that poor glucose tolerance is associated with lower EC in pediatric patients with CF. There was a significant relationship between glucose and insulin values obtained by OGTT with EC in a sample of non-diabetic patients with preserved lung function. Future studies are warranted to confirm these findings and investigate the potential role of exercise in the management or prevention of CFRD.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiopulmonary exercise test (CPET); cystic fibrosis (CF); cystic fibrosis-related diabetes (CFRD); exercise capacity; oral glucose tolerance test (OGTT)

Mesh:

Substances:

Year:  2017        PMID: 29115018     DOI: 10.1002/ppul.23906

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  3 in total

1.  The Effect of Dysglycaemia on Changes in Pulmonary and Aerobic Function in Cystic Fibrosis.

Authors:  Owen W Tomlinson; Anna L E Stoate; Lee Dobson; Craig A Williams
Journal:  Front Physiol       Date:  2022-03-30       Impact factor: 4.566

2.  Physiological predictors of cardiorespiratory fitness in children and adolescents with cystic fibrosis without ventilatory limitation.

Authors:  Marcella Burghard; Tim Takken; Merel M Nap-van der Vlist; Sanne L Nijhof; C Kors van der Ent; Harry G M Heijerman; H J Erik Hulzebos
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 4.031

3.  Short-Term Effects of Elexacaftor/Tezacaftor/Ivacaftor Combination on Glucose Tolerance in Young People With Cystic Fibrosis-An Observational Pilot Study.

Authors:  Insa Korten; Elisabeth Kieninger; Linn Krueger; Marina Bullo; Christa E Flück; Philipp Latzin; Carmen Casaulta; Claudia Boettcher
Journal:  Front Pediatr       Date:  2022-04-21       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.